Biosurgery Market - Forecasts from 2018 to 2023

Biosurgery Market - Forecasts from 2018 to 2023

The biosurgery market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. Biosurgery products make use of biologically active products and are used in the facilitation of hemostasis and sealing of the tissues during surgery. Rising geriatric population, increasing surgeries, increasing sports-related injuries, and trauma injuries are driving the growth of the global biosurgery market in the forecast period. The high cost of biosurgery products and costly surgical procedures may, however, hamper the growth of the global biosurgery market.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the biosurgery value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the biosurgery market.

Major industry players profiled as part of the report are Baxter International Inc., B. Braun Melsungen AG, C. R. Bard, Inc., Johnson & Johnson Services, Inc. and Medtronic among others.

Segmentation

The biosurgery market has been analyzed through following segments:

By Product

Fibrin & Collagen Sealant

Hemostat

Biological Mesh

Soft Tissue Attachments

Others


By Application

Orthopaedic

Cardiovascular

Reconstructive

Gynecology


By Geography

North America

USA

Canada

Mexico

Others


South America

Brazil

Argentina

Others


Europe

Germany

France

United Kingdom

Spain

Others


Middle East and Africa

Saudi Arabia

Israel

Others


Asia Pacific

China

Japan

South Korea

India

Others


Target audience

Manufacturers

Suppliers

Distributors

Service Providers

Government Agencies

Research Organizations

Consultants


Key insights offered

What will be the biosurgery market size from 2017 to 2023?

How are the major drivers and restraints affecting the biosurgery market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY  
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. BIOSURGERY  MARKET BY PRODUCT
5.1. Fibrin & Collagen Sealant
5.2. Hemostat
5.3. Biological Mesh
5.4. Soft Tissue Attachments
5.5. Others
6. BIOSURGERY  MARKET BY APPLICATION
6.1. Orthopaedic
6.2. Cardiovascular
6.3. Reconstructive
6.4. Gynecology
7. BIOSURGERY  MARKET BY GEOGRAPHY
7.1. North America
7.1.1. USA
7.1.2. Canada
7.1.3. Mexico
7.1.4. Others
7.2. South America
7.2.1. Brazil
7.2.2. Argentia
7.2.3. Others
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. United Kingdom
7.3.4. Spain
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. Israel
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. South Korea
7.5.4. India
7.5.5. Others
8. COMPETITIVE INTELLIGENCE
8.1.  Market Share of Key Players
8.2.  Recent Investment and Deals
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. Baxter International Inc.
9.1.1. Company Overview
9.1.2. Financials
9.1.3. Products and Services
9.1.4. Recent Developments
9.2. B. Braun Melsungen AG
9.2.1. Company Overview
9.2.2. Financials
9.2.3. Products and Services
9.2.4. Recent Developments
9.3.  C. R. Bard, Inc.
9.3.1. Company Overview
9.3.2. Financials
9.3.3. Products and Services
9.3.4. Recent Developments
9.4.  Johnson & Johnson Services, Inc.
9.4.1. Company Overview
9.4.2. Financials
9.4.3. Products and Services
9.4.4. Recent Developments
9.5.  Medtronic
9.5.1. Company Overview
9.5.2. Financials
9.5.3. Products and Services
9.5.4. Recent Developments
9.6. MAQUET Holding B.V. & Co. KG
9.6.1. Company Overview
9.6.2. Financials
9.6.3. Products and Services
9.6.4. Recent Developments
9.7. Cohera Medical, Inc.
9.7.1. Company Overview
9.7.2. Financials
9.7.3. Products and Services
9.7.4. Recent Developments
9.8. Integra LifeSciences Corporation
9.8.1. Company Overview
9.8.2. Financials
9.8.3. Products and Services
9.8.4. Recent Developments
9.9. Hemostasis, LLC
9.9.1. Company Overview
9.9.2. Financials
9.9.3. Products and Services
9.9.4. Recent Developments
9.10. sanofi-aventis U.S. LLC
9.10.1. Company Overview
9.10.2. Financials
9.10.3. Products and Services
9.10.4. Recent Developments
LIST OF FIGURES
LIST OF TABLES
DISCLAIMER 

Baxter International Inc.

B. Braun Melsungen AG

C. R. Bard, Inc.

Johnson & Johnson Services, Inc.

Medtronic

MAQUET Holding B.V. & Co. KG

Cohera Medical, Inc.

Integra LifeSciences Corporation

Hemostasis, LLC

sanofi-aventis U.S. LLC

  • SKU:
  • Publishing Date: 2018-10-25
  • Product Code: 1
  • Availability: In Stock
  • $3,800.00
  • Ex Tax: $3,800.00

Available Options